25 May 2013
Keywords: strong, ph, iii, data, indevus, sanctura, xr
Article | 17 July 2006
US drugmaker Indevus Pharmaceuticals says that Sanctura XR (trospium Cl), the once-daily formulation of its currently-marketed overactive
bladder drug, met ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 July 2006
24 May 2013
© 2013 thepharmaletter.com